Resources

Publications

05/26/2022
- Oncology
CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions
ASCO 2022
05/26/2022
- Oncology
Targeting B7-H3 in Prostate Cancer: Phase 2 Trial in Localized Prostate Cancer Using the Anti-B7-H3 Antibody Enoblituzumab, With Biomarker Correlatives
ASCO 2022
05/26/2022
- Oncology
Comparative Analysis of the Targetable Landscape in KRAS-Mutated and Wild-Type Pancreatic Adenocarcinoma
ASCO 2022
05/26/2022
- Oncology
Identifying Biomarkers Associated With Disease-Free Survival in Early-Stage Lung Cancer
ASCO 2022
05/26/2022
- Oncology
Operational Metrics for the ELAINE II Study Combining a Traditional Approach With A Just-in-Time Model
ASCO 2022
05/26/2022
- Oncology
Genetic Ancestry Differences in Tumor Mutation and Expression in Early and Average Onset Colorectal Cancer
ASCO 2022
05/26/2022
- Oncology
Paired Tumor/Normal Sequencing Reduces Apparent Racial Differences In Tumor Mutational Burden (TMB)
ASCO 2022
05/26/2022
- Oncology
Natural Language Processing-Optimized Case Selection for Real World Evidence Studies
ASCO 2022
05/26/2022
- Oncology
Real World Data To Enable Large-Scale Assessment of WHO CNS5 Glioma Classification
ASCO 2022
05/26/2022
- Oncology
Comparative Analysis of Microsatellite Instability-High (MSI-H) BRAF V600E–Mutated Versus MSI-H BRAFwild Type Colorectal Cancers (CRC), Including Tumor Microenvironment (TME), Associated Genomic Alterations, and Immuno-Metabolomic Biomarkers
ASCO 2022

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28